The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Gergely, B.,
Vereb, M. A.,
Rebenku, I.,
Szöőr, Á.,
Vereb, G.:
Breaking the barrier: Synergistic 2B4.4-1BB signaling potentiates HER2-CAR NK cells to penetrate and destroy ADCC-resistant tumors.
Cancer Lett. 651, 1-9, (article identifier: 218534), 2026.
Hajdara, A.,
Szöőr, Á.,
Murányi, J.,
Brunyánszki, A.,
Rácz, G.,
Cioca, D.,
Gordos, A.,
Bata, N.,
Nagy, N. M.,
Fedorcsák, I.,
Sipos, L.,
Kisgyörgy, M.,
Megyeri, M.,
Péterfi, Z.,
Farkas, S.,
Hornyák, P.:
Directed evolution of chlorotoxin enhances MMP-2 recognition and improves CAR-T-cell activity in glioblastoma models in vitro.
Front. Bioeng. Biotechnol. 14, 1-16, 2026.
Gergely, B.,
Vereb, M. A.,
Rebenku, I.,
Vereb, G.,
Szöőr, Á.:
Targeting HER2-Positive Solid Tumors with CAR NK Cells: CD44 Expression Is a Critical Modulator of HER2-Specific CAR NK Cell Efficacy.
Cancers. 17 (5), 1-17, (article identifier: 731), 2025.
Kraja, F. P.,
Jurisic, V. B.,
Hromic-Jahjefendic, A.,
Rossopoulou, N.,
Katsila, T.,
Mirjacic Martinovic, K.,
De Las Rivas, J.,
Diaconu, C. C.,
Szöőr, Á.:
Tumor-infiltrating lymphocytes in cancer immunotherapy: from chemotactic recruitment to translational modeling.
Front. Immunol. 16, 1-21, (article identifier: 1601773), 2025.
Tóth, A.,
Lente, G.,
Csiki, D. M.,
Balogh, E.,
Szöőr, Á.,
Nagy, B. J.,
Jeney, V.:
Activation of PERK/eIF2α/ATF4/CHOP branch of endoplasmic reticulum stress response and cooperation between HIF-1α and ATF4 promotes Daprodustat-induced vascular calcification.
Front. Pharmacol. 15, 1-12, (article identifier: 1399248), 2024.
Ababneh, H. M.,
Tóth, A.,
Lente, G.,
Balogh, E.,
Csiki, D. M.,
Nagy, B. J.,
Szöőr, Á.,
Jeney, V.:
High phosphate and calcium induce osteoblastic phenotype switching and calcification of corneal epithelial cells in a Runx2-dependent and synergistic manner; a possible mechanism of chronic kidney disease-associated corneal calcification.
Biochim. Biophys. Acta. Mol. Basis Dis. 1870 (5), 1-20, (article identifier: 167171), 2024.
Lupsa, N.,
Érsek, B.,
Böröczky, C.,
Kis, D.,
Szarka, E.,
Lumniczky, K.,
Sáfrány, G.,
Zádori, Z. S.,
Szöőr, Á.,
Buzás, E.,
Pos, Z.:
High sensitivity of host Helios+/Neuropilin-1+ Treg to pretransplant conditioning hampers development of OX40 bright/integrin-β7+ regulatory cells in acute gastrointestinal GvHD.
Eur. J. Immunol. 54 (6), 1-18, (article identifier: 2350619), 2024.
Barden, M.,
Elsenbroich, P. R.,
Haas, V.,
Ertelt, M.,
Pervan, P.,
Velas, L.,
Gergely, B.,
Szöőr, Á.,
Harrer, D. C.,
Bezler, V.,
Holzinger, A.,
Friis, R. U. W.,
Vereb, G.,
Schütz, G.,
Schoeder, C. T.,
Hombach, A. A.,
Abken, H.:
Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell function.
J. Immunother. Cancer. 12 (12), 1-14, (article identifier: 010208), 2024.
Nagy, L.,
Mezősi-Csaplár, M.,
Rebenku, I.,
Vereb, G.,
Szöőr, Á.:
Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC.
Front. Immunol. 15, 1-38, (article identifier: 1365172), 2024.
Barden, M.,
Holzinger, A.,
Velas, L.,
Mezősi-Csaplár, M.,
Szöőr, Á.,
Vereb, G.,
Schütz, G.,
Hombach, A. A.,
Abken, H.:
CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation.
Front. Immunol. 14, 1-13, (article identifier: 1110482), 2023.
Mezősi-Csaplár, M.,
Szöőr, Á.,
Vereb, G.:
CD28 and 41BB Costimulatory Domains Alone or in Combination Differentially Influence Cell Surface Dynamics and Organization of Chimeric Antigen Receptors and Early Activation of CAR T Cells.
Cancers (Basel). 15 (12), 3081-3097, (article identifier: 3081), 2023.
Cserepes, M.,
Nelhűbel, G. A.,
Meilinger-Dobra, M.,
Herczeg, A.,
Türk, D.,
Hegedűs, Z.,
Svajda, L.,
Rásó, E.,
Ladányi, A.,
Csikó, K. G.,
Kenessey, I.,
Szöőr, Á.,
Vereb, G.,
Remenár, É.,
Tóvári, J.:
EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer.
Cancers (Basel). 14 (10), 1-15, (article identifier: 2407), 2022.
